Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Because of the coming data lock and also mainly because of the recent JAMA (may 21st) Results from the Checkmate 143 clinical trial where the primary end point of median overall survival did not differ significantly (FDA approved Avastin didn't do better).
Well because it needed another combination therapy, that's where we come in with Dr. Linda Liau's DCVAX-L. Just like the trial going on now at UCLA Keytruda/Dcvax combo, will be the powerhouse combo for glioblastoma.
Wouldnt that be amazing, i hope that plays out... that would be an EPIC squeeze $6+
Agree, now Dr Duffy who is once Merck’s Research Scientific Director in the Keytruda program has full knowledge of the efficacy and safety of dcvax-L & D.
Merck has stated they wanted to strengthen their vaccine program. As we know their star $7 billion and growing oncology franchise Keytruda is now in combo trials with our dcvax-L.
So the multibillion-dollar question is...will Merck make a major acquisition deal?
Boom! $25+
Excellent!
Yes, well said... they will pr data lock for this main reason you stated:
“And if they PR Data Lock then that would be a show of good faith and would help begin to restore the shattered trust of many shareholders and markets.”
Excellent analysis, i believe it’s not a coincidence. It was a strategic collaboration between a Buyer and Seller, hehe...
I agree, but higher.
It’s fine, it’s just casual convo between fellow shareholders on how they’ll spend their millions. It could be cars, houses, sailboats, bibles, or anything.
Awesome
That’s great tryn2, really great... more to come.
Correct, plus we are very much under priced for a bio company that is about to release phase 3 results soon in a Glioblastoma Treatment Market that is in the billions. Also market is taking notice now by our increased volume especially today 9 million!
NOPE, We have Sushifishman, clay’s kryptonite
Well, next week when we pass over .34 will get CNBC attention again and we will be mentioned.... i hope! ;)
Good deal, smart.
Can u sell your google, nflx, FB , and tsla too and buy boatload at .32
Optivo Fail primary endpoints, but not dcvax-L we will be the standard!
I’m fine, wearing a mask and full body condom and enjoying Level 2... .33 coming!
.32! Boom
Gladiators on way... boom!
I see that too, its our time and its just beginning.
thanks, time to cover sshorties! doomsday for you guys.
Nice, there are more coming... gold rush!
Added 38k at 0.25475 glad it all filled at one shot.
Steady rise continues. Great looking chart too!
Marzan, sorry OFF Topic... have you checked on Matinas BioPharma (MTNB). Their product MAT9001 vs Vascepa will go into Phase 3 this Dec2020. They also use strictly EPA and on their phase 2 head to head vs AMRN it came out 300% better. Baker Bros also invested 2million worth as of 2019. What are your thoughts?
Will buy on the dip
Excellent!
Agreed.
Where are the rich LPCN shareholders?
Actually, early July 4th NWBO fireworks.
Epic! Squeeze
Awesome post!
Nice! Cheers!
Hey Kam! I added last Thursday a bit and added again today at .1681
Correct Dr Duffy’s mission accomplished, data lock close and then TLD. Boom!!!
Hehe still not satisfied loading up at .169 ;)
Longest gbm trial = home run loooong tail, boom!
Bought more lottery tickets today... yeah!